AARTI PHARMALABS
Back to Cashflow Statement
|
AARTI PHARMALABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹65 Cr | ₹9.72 Cr | ₹-163 Cr | ₹260 Cr | - |
What is the latest Cash Flow from Financing Activities ratio of AARTI PHARMALABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹65 Cr |
| Mar2024 | ₹9.72 Cr |
| Mar2023 | ₹-163 Cr |
| Mar2022 | ₹260 Cr |
| Mar2021 | - |
How is Cash Flow from Financing Activities of AARTI PHARMALABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹65 Cr | 572.92 | |
| Mar2024 | ₹9.72 Cr | Positive | |
| Mar2023 | ₹-163 Cr | Negative | |
| Mar2022 | ₹260 Cr | 0 | |
| Mar2021 | - | - | |
Compare Cash Flow from Financing Activities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹6,943.5 Cr | -2.2% | 0.6% | 27.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,698.0 Cr | 0.2% | -1.3% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,866.0 Cr | 1.9% | -6.7% | 0.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,062.0 Cr | 1.3% | 2.9% | 28.7% | Stock Analytics | |
| CIPLA | ₹108,412.0 Cr | 1.3% | -8.5% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,805.0 Cr | 1.3% | 3.8% | 4.5% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | -2.2% |
0.6% |
27.8% |
| SENSEX | 0.6% |
0.1% |
9.2% |
You may also like the below Video Courses